Keywords
How to Cite
Abstract
Give the same dose of the same drug to two patients, and one may be cured while the other is harmed—a problem as old as prescribing itself. Much of that variability is written in the genome. Pharmacogenetics, the study of how inherited variation modifies drug response, has matured from a laboratory curiosity into a clinical discipline with published dosing guidelines for more than a hundred drugs.
References
1. Swen JJ, van der Wouden CH, Manson LE, et al. A 12-gene pharmacogenetic panel to prevent adverse drug reactions: an open-label, multicentre, controlled, cluster randomised crossover implementation study (PREPARE). Lancet. 2023;401:347–356.
2. Preventing adverse drug reactions and more: current clinical use of pharmacogenetic testing. Pharmacogenomics J / review, 2025 (PMC12268254).
3. Relling MV, Klein TE. CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network. Clin Pharmacol Ther. 2011;89:464–467.
4. Caudle KE, Dunnenberger HM, Freimuth RR, et al. Standardizing terms for clinical pharmacogenetic test results: consensus terms from CPIC. Genet Med. 2017;19:215 223.
5. Pereira NL, Farkouh ME, So D, et al. CPIC guideline for CYP2C19 genotype and clopidogrel therapy. Clin Pharmacol Ther. 2022;112:959–967.
This work is licensed under a Creative Commons Attribution 4.0 International License.
